We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13.1B
AUM Growth
+$754M
(+6.1%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
8.89%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
1,188
New
182
Increased
340
Reduced
340
Closed
221
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$379M |
| 2 |
NVIDIA
NVDA
|
+$323M |
| 3 |
Amazon
AMZN
|
+$133M |
| 4 |
UnitedHealth
UNH
|
+$97.5M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$86.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$89.2M |
| 2 |
ExxonMobil
XOM
|
+$83.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 4 |
CVS Health
CVS
|
+$82.2M |
| 5 |
Eli Lilly
LLY
|
+$66.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Healthcare | 11.42% |
| 3 | Energy | 7.9% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Financials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
301
Charles Schwab
SCHW
$177B
| $4.37M | 0.03% |
79,586
-126,804
| -61% | -$7.66M |
|
|
CEQP
302
DELISTED
Crestwood Equity Partners LP
CEQP
| $4.32M | 0.03% |
147,600
| – | – |
|
303
Amphenol
APH
$188B
| $4.31M | 0.03% |
102,644
-231,644
| -69% | -$9.96M |
|
304
Rogers Communications
RCI
$17.7B
| $4.26M | 0.03% |
110,667
-16,673
| -13% | -$699K |
|
305
Maravai LifeSciences
MRVI
$997M
| $4.08M | 0.03% |
408,108
-1,394,035
| -77% | -$15.3M |
|
306
Capri Holdings
CPRI
$1.77B
| $4M | 0.03% |
76,080
+75,986
| +80,836% | +$3.45M |
|
307
W.R. Berkley
WRB
$28B
| $3.99M | 0.03% |
94,272
+42,291
| +81% | +$1.75M |
|
308
Philip Morris
PM
$301B
| $3.94M | 0.03% |
42,556
-408,232
| -91% | -$39.3M |
|
309
Northern Trust
NTRS
$22.2B
| $3.89M | 0.03% |
55,977
+23,706
| +73% | +$1.79M |
|
310
CoStar Group
CSGP
$11.3B
| $3.88M | 0.03% |
50,447
+25,568
| +103% | +$2.12M |
|
311
Boston Scientific
BSX
$65.8B
| $3.8M | 0.03% |
72,029
-16,624
| -19% | -$872K |
|
312
Zions Bancorporation
ZION
$10.1B
| $3.75M | 0.03% |
107,615
+100,580
| +1,430% | +$3.51M |
|
313
Viper Energy
VNOM
$8.81B
| $3.71M | 0.03% |
132,900
| – | – |
|
314
Invesco NASDAQ 100 ETF
QQQM
$95.1B
| $3.64M | 0.03% |
24,553
+236
| +1% | +$36K |
|
315
Tyson Foods
TSN
$20.2B
| $3.63M | 0.03% |
71,988
+49,581
| +221% | +$2.64M |
|
316
Agree Realty
ADC
$9.68B
| $3.59M | 0.03% |
+65,000
| New | +$4.06M |
|
317
FTAI Infrastructure
FIP
$500M
| $3.58M | 0.03% |
1,112,600
-250,000
| -18% | -$864K |
|
318
PACCAR
PCAR
$69.6B
| $3.51M | 0.03% |
41,335
-54,336
| -57% | -$4.62M |
|
319
Invesco S&P 500 Quality ETF
SPHQ
$19.4B
| $3.51M | 0.03% |
70,078
+1,492
| +2% | +$76.5K |
|
320
Skyworks Solutions
SWKS
$9.06B
| $3.49M | 0.03% |
35,409
-24,893
| -41% | -$2.65M |
|
|
FISV
321
Fiserv Inc
FISV
$27.2B
| $3.48M | 0.03% |
+30,789
| New | +$3.79M |
|
322
Roper Technologies
ROP
$36.3B
| $3.3M | 0.03% |
6,814
+704
| +12% | +$345K |
|
323
Southern Company
SO
$110B
| $3.28M | 0.03% |
50,757
+18,244
| +56% | +$1.27M |
|
324
Equitable Holdings
EQH
$13.1B
| $3.27M | 0.03% |
115,053
+114,099
| +11,960% | +$3.22M |
|
325
Capital One
COF
$124B
| $3.26M | 0.03% |
33,613
+183
| +0.5% | +$19.6K |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q3 2023 Portfolio in Review
As of Q3 2023, Natixis held 1,188 positions worth $13.1B, up 6.1% from $12.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Natixis deployed $1.16B of net new capital in Q3 2023, opening 182 new positions and adding to 340 existing holdings. Its largest new stake was Oneok: 965,015 shares worth $61.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $89.2M trimmed.
- Natixis's largest Q3 2023 buy was Oneok: 965,015 shares worth $61.2M.
- Natixis added most to Apple in Q3 2023, an estimated $379M increase.
- Natixis's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $89.2M.
- Natixis fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $83.1M.
- Natixis's ten largest holdings make up 38% of its $13.1B portfolio in Q3 2023.
- Natixis opened 182 new positions and closed 221 in Q3 2023.
- Natixis's portfolio value rose 6.1% quarter-over-quarter to $13.1B.
Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.